immunology News

Cambridge Healthtech Institute’s Third Annual Anti-Inflammatories: Small Molecule Approaches will be held April 17-18, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount expires January 27th.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

This exciting event will bring together some of the leading TB researchers in the world to discuss the latest development in TB therapy.

This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 17-18, 2011 at the DoubleTree Hotel in Bethesda, MD.

Desmogleins are members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 is autoantigen of the autoimmune disease pemphigus vulgaris, and plays role in squamous cell cancer.

Join the top 50 Pharma companies as they discuss some of the most prominent issues that stand in the way of the successful harnessing of the vast potential that this process possess

Stratedigm announces the release of its 4 laser/14 color flow cytometry analyzer. This platform complements the company's other 2 flow cytometers the SE500 and S1000.

Therapeutic antibodies are central to pharmaceutical development; needless to say, emphasis is continually on developing new methods and improving those already in place. Play an active role in the war against disease – register online today!

On December 8, 2010, in a paper published in ‘Blood’, a patient is reported as being cured from HIV nearly 4 years after a bone marrow transplant was performed.

Is it possible for you to avoid your allergy triggers?

SMi present their 4th annual Biomarkers Summit Monday 31st January & Tuesday 1st February 2011, Crowne Plaza City, Central London, UK Sponsored by: Caprotec, Cell Signalling Technology, Genstruct, Millipore, RBM, Quest Diagnostics

East Tennessee Center for Clinical Research has a team that is dedicated to the highest performance standards of conducting clinical research studies while maintaining a high level of care for subjects.

...everyone has specific allergic triggers, knowing what you are allergic to is important for effective treatment.

SMi present their 4th annual... Biomarkers Summit Discovery, Validation and Qualification Monday 31st January & Tuesday 1st February 2011 Crowne Plaza City, Central London, UK Sponsored by: Caprotec Genstruct RBM

Monday 31st January & Tuesday 1st February 2011 Crown Plaza City, London, www.smi-online.co.uk/preclinical-biomarkers.asp

New Medical Devices research report from GlobalData is now available from Fast Market Research

ISCO Chairman Kenneth Aldrich to speak on stem cell research at the Rodman & Renshaw 12th Annual Global Investment Conference on Healthcare on September 15, 2010 in New York City.

A subset of children with asthma suffers from severe, treatment-resistant disease associated with more illness and greater allergic hypersensitivity.

Extreme summer heat is gripping the central states, Allergy, Asthma & Sinus Center of Knoxville, TN is reminding everyone of the dangers of asthma.

International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue.

Chief Scientific Officer, Dr. Tamar Ben Yedidia, will provide an overview of the Company's technology and clinical development progress at two upcoming biopharma industry conferences in Israel and Barcelona, Spain

An insightful and in-depth presentation of the most up-to-date clinical and research findings and historical perspectives on pediatric interstitial lung disease (ILD)

Hypnosis has potential therapeutic value in children with respiratory disorders for alleviating symptoms such as habit cough or unexplained sensations of difficulty breathing and for lessening a child’s discomfort during medical procedures.

Michael Karin, Professor of Pharmacology Tumor Growth Invasion & Metastasis at UCSD to Give Keynote Speech at GTCbio’s 7th Cytokines & Inflammation Conference on January 29-30, 2009 in San Diego, CA

GTCbio just announced its 7th Annual Conference on Cytokines & Inflammation scheduled for January 29-30, 2009 in Sunny San Diego, California.

Conference to be held at 22nd - 23rd January 2009, BSG Conference Centre, London, UK

Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentaion at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007